Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
EuroIntervention 2018;14:e570-e579 published online October 2017 published online e-edition August 2018. DOI: 10.4244/EIJ-D-17-00461
Taku Asano1,2, MD; Yuki Katagiri1, MD; Carlos Collet1, MD; Erhan Tenekecioglu3, MD; Yosuke Miyazaki3, MD, PhD; Yohei Sotomi1, MD; Giovanni Amoroso4, MD, PhD; Adel Aminian5, MD; Salvatore Brugaletta6, MD, PhD; Mathias Vrolix7, MD; Rosana Hernandez-Antolín8, MD, PhD; Pim van de Harst9,10, MD, PhD; Andres Iñiguez11, MD, PhD; Luc Janssens12, MD; Pieter C. Smits13, MD, PhD; Joanna Wykrzykowska1, MD, PhD; Vasco Gama Ribeiro14, MD; Helder Pereira15, MD; Pedro Canas da Silva16, MD; Jan J. Piek1, MD, PhD; Johan H.C. Reiber17, PhD; Clemens von Birgelen18, MD, PhD; Manel Sabaté6, MD, PhD; Yoshinobu Onuma3,19*, MD, PhD; Patrick W. Serruys20, MD, PhD
1. Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; 2. Department of Cardiology, St. Luke’s International Hospital, Tokyo, Japan; 3. Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; 4. Onze Lieve Vrouwe Gasthu
Aims: Quantitative flow ratio (QFR) based on three-dimensional quantitative coronary angiography (3D-QCA) is a novel method to assess physiological functionality after treatment with sten